NEW YORK, Sept. 9, 2020 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international shareholder and consumer rights litigation firm, reminds investors of its investigation into whether ECMOHO Limited ("ECMOHO" or the "Company") MOHO or certain of its officers and directors violated federal securities laws. If you purchased ECMOHO securities pursuant and/or traceable to ECMOHO's initial public offering ("IPO") in November 2019, you are encouraged to contact Scott+Scott attorney Jonathan Zimmerman at (888) 398-9312 for more information.
ECMOHO purports to be one of China's leading, integrated solution providers in the rapidly growing non-medical health and wellness market.
On or about November 12, 2019, ECMOHO commenced an IPO, issuing 4,375,000 American Depository Shares (ADSs), representing 17,500,000 Class A Ordinary Shares, to the investing public at $10 per ADS.
On March 30, 2020, ECMOHO announced its preliminary financial results for fiscal year 2019, reporting revenue of approximately $329 million and net income between $3.1 million and $3.7 million.
Shares of ECMOHO fell by 46% the next day.
What You Can Do
If you purchased ECMOHO securities, and you wish to discuss this investigation, please contact attorney Jonathan Zimmerman at (888) 398-9312, or at jzimmerman@scott-scott.com, or visit the ECMOHO investigation page on our website at https://scott-scott.com/investigation/ecmoho-limited/.
About Scott+Scott Attorneys at Law LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.
Attorney Advertising
CONTACT:
Jonathan Zimmerman
Scott+Scott Attorneys at Law LLP
230 Park Ave, 17th Floor, NY, NY 10169
(888) 398-9312
jzimmerman@scott-scott.com
SOURCE Scott+Scott Attorneys at Law LLP
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
